642 related articles for article (PubMed ID: 16524052)
1. [Histocompatibility tests in a transplantation program].
de-Leo-Cervantes C
Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
4. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
5. [Significance of histocompatibility tests].
Nishigaki F; Nozaki M; Nakamura A; Taniguchi M; Kobayashi K; Hirano T
Rinsho Byori; 1990 Feb; 38(2):151-6. PubMed ID: 2139476
[TBL] [Abstract][Full Text] [Related]
6. Utility of the virtual crossmatch in solid organ transplantation.
Amico P; Hönger G; Steiger J; Schaub S
Curr Opin Organ Transplant; 2009 Dec; 14(6):656-61. PubMed ID: 19741534
[TBL] [Abstract][Full Text] [Related]
7. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
[TBL] [Abstract][Full Text] [Related]
8. Histocompatibility testing for highly sensitized transplant candidates.
Saidman SL
Transplant Proc; 2007 Apr; 39(3):673-5. PubMed ID: 17445570
[TBL] [Abstract][Full Text] [Related]
9. The changing role of antibody testing in transplantation.
Leffell MS; Montgomery RA; Zachary AA
Clin Transpl; 2005; ():259-71. PubMed ID: 17424745
[TBL] [Abstract][Full Text] [Related]
10. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
[TBL] [Abstract][Full Text] [Related]
11. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
12. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
13. Alloantibodies and the outcome of cadaver kidney allografts.
Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
[TBL] [Abstract][Full Text] [Related]
14. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
[TBL] [Abstract][Full Text] [Related]
15. Influence of HLA matching on kidney graft survival.
Thorsby E; Solheim BG; Ottem A; Flatmark A; Enger E
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):7-10. PubMed ID: 133457
[TBL] [Abstract][Full Text] [Related]
16. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ.
Tyan DB; Li VA; Czer L; Trento A; Jordan SC
Transplantation; 1994 Feb; 57(4):553-62. PubMed ID: 8116041
[TBL] [Abstract][Full Text] [Related]
18. The crossmatch may still be the most clinically relevant histocompatibility test performed.
Kerman R; Lappin J; Kahan B; Katz S; McKissick E; Hosek K; Acorda N; Wooley N; Hoover A; Miller K; Rodriguez L; Moore B; Melcher P; Biedermann B; Van Buren C
Clin Transpl; 2007; ():227-9. PubMed ID: 18642454
[TBL] [Abstract][Full Text] [Related]
19. Crossmatch procedures used in organ transplantation.
Gebel HM; Lebeck LK
Clin Lab Med; 1991 Sep; 11(3):603-20. PubMed ID: 1934966
[TBL] [Abstract][Full Text] [Related]
20. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]